U.S. flag

An official website of the United States government

NM_022089.4(ATP13A2):c.2348G>A (p.Arg783Gln) AND not specified

Germline classification:
Likely benign (1 submission)
Last evaluated:
Feb 8, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003994006.1

Allele description [Variation Report for NM_022089.4(ATP13A2):c.2348G>A (p.Arg783Gln)]

NM_022089.4(ATP13A2):c.2348G>A (p.Arg783Gln)

Gene:
ATP13A2:ATPase cation transporting 13A2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p36.13
Genomic location:
Preferred name:
NM_022089.4(ATP13A2):c.2348G>A (p.Arg783Gln)
HGVS:
  • NC_000001.11:g.16990191C>T
  • NG_009054.1:g.26738G>A
  • NM_001141973.3:c.2333G>A
  • NM_001141974.3:c.2333G>A
  • NM_022089.4:c.2348G>AMANE SELECT
  • NP_001135445.1:p.Arg778Gln
  • NP_001135446.1:p.Arg778Gln
  • NP_071372.1:p.Arg783Gln
  • LRG_834t1:c.2348G>A
  • LRG_834:g.26738G>A
  • LRG_834p1:p.Arg783Gln
  • NC_000001.10:g.17316686C>T
  • NM_022089.2:c.2348G>A
  • NM_022089.3:c.2348G>A
Protein change:
R778Q
Links:
dbSNP: rs137955309
NCBI 1000 Genomes Browser:
rs137955309
Molecular consequence:
  • NM_001141973.3:c.2333G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001141974.3:c.2333G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_022089.4:c.2348G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004813230Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Likely benign
(Feb 8, 2024)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV004813230.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Variant summary: ATP13A2 c.2348G>A (p.Arg783Gln) results in a conservative amino acid change located in the P-type ATPase, haloacid dehalogenase domain (IPR044492) of the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00037 in 282148 control chromosomes, predominantly at a frequency of 0.0038 within the African or African-American subpopulation in the gnomAD database, including 1 homozygote. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 20 fold of the estimated maximal expected allele frequency for a pathogenic variant in ATP13A2 causing Neurodegeneration With Brain Iron Accumulation phenotype (0.00019), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. To our knowledge, no occurrence of c.2348G>A in individuals affected with Neurodegeneration With Brain Iron Accumulation and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 465258). Based on the evidence outlined above, the variant was classified as likely benign.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 24, 2024